Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons

Transplantation

Volumn 72, Issue 7, 2001, Pages 1278-1285

  Basker, Murali ^a   Alwayn, Ian P J ^a   Buhler, Leo ^a   Harper, David ^b   Abraham, Sonny ^b   Kruger Gray, Huw ^b   DeAngelis, Holly ^b   Awwad, Michel ^b   Down, Julian ^b   Rieben, Robert ^c   White Scharf, Mary E ^b   Sachs, David H ^a   Thall, Aron ^b   Cooper, David K C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BioTransplant Inc   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; LIPOSOME; MEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CELL TRANSPLANTATION; CONTROLLED STUDY; ERYTHROPHAGOCYTOSIS; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; STEM CELL; SWINE;

EID: 0035886063     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200110150-00017     Document Type: Article

References (42)

1. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen
2. Natural killer cells weakly resist engraftment of allogeneic long-term multilineage-repopulating hematopoietic stem cells
3. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance
4. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
5. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model
6. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys
7. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys
8. Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen
9. Cross-species bone marrow transplantation: Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat -> mouse)
10. Demonstration of multilineage chimerism in a nonhuman primate concordant xenograft model
11. Hyperacute rejection in the guinea pig-to-rat model without formation of the membrane attack complex
12. C6 produced by macrophages contributes to cardiac allograft rejection
13. Dendritic cells and macrophages in lung allografts. A role in chronic rejection?
14. Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2 MDP liposomes
15. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice
16. The effect of macrophage depletion on delayed xenograft rejection: Studies in the guinea pig-to-C6-deficient rat heart transplantation model
17. IL-10/Fc inhibits macrophage function and prolongs pancreatic islet xenograft survival
18. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study
19. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications
20. Minireview. The liposome-mediated macrophage suicide technique
21. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin
22. Treatment effects on chronic idiopathic thrombocytopenic purpura
23. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis
24. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action
25. Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: A case report
26. Radiolabeled latex particles in the investigation of phagocytosis in vivo: Clearance curves and histological observations
27. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption
28. Inhibition of platelet aggregation in baboons: Therapeutic implications for xenotransplantation
29. Peripheral blood progenitor cell mobilization and leukapheresis in pigs
30. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates
31. Effect of pig-specific cytokines on mobilization of hematopoietic progenitor cells in pigs and on pig bone marrow engraftment in baboons
32. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: Evidence for accessory cell involvement in expansion of immature CD34+CD38- cells
33. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody-experience with 320 aphereses in baboons
34. The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies
35. Mixed chimerism as an approach for the induction of transplantation tolerance
36. CD40-CD154 pathway blockade register host macrophages to induce humoral unresponsiveness to pig hematopoietic cells in baboons
37. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation
38. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies
39. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin
40. Modulation of cytokine production by immunoglobulins for intravenous use (IVIg)
41. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance